MolNFT v1 · #24668 · protein
Benzamidine in complex with bovine trypsin variant X(TRIPLE.GLU)BT.A1
1V2M: “Benzamidine in complex with bovine trypsin variant X(TRIPLE.GLU)BT.A1”. X-ray diffraction. MolNFT v1 #24668 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 1V2M
- Type
- protein
- Length
- 223 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- P00760
Structure
x-ray diffraction · 1 distinct chain.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| T | — | protein | 223 | — | P00760 |
Compared structures
- 1V2M · Benzamidine in complex with bovine trypsin variant X(triple.Glu)bT.A1 · the same entry in another collection · chain T against T, TM-score 1.00
- 1TNL · Prediction of novel serine protease inhibitors · a predicted model of the same protein · chain T against A, TM-score 0.99
- 1TNH · Prediction of novel serine protease inhibitors · a predicted model of the same protein · chain T against A, TM-score 0.99
- 1TNI · Prediction of novel serine protease inhibitors · a predicted model of the same protein · chain T against A, TM-score 0.99
- 1TNJ · Prediction of novel serine protease inhibitors · a predicted model of the same protein · chain T against A, TM-score 0.99
- 1TNG · Prediction of novel serine protease inhibitors · a predicted model of the same protein · chain T against A, TM-score 0.99
- 1TNK · Prediction of novel serine protease inhibitors · a predicted model of the same protein · chain T against A, TM-score 0.99
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P00760
- Elsewhere: RCSB PDB 1V2M · PDBe 1V2M · UniProt P00760
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.